ORMP · Oramed Pharmaceuticals Inc.
$3.97
-0.20 (-4.80%)
At close · Jul 29
Market Cap
$170.66M
Shares
40.93M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-05-04 | 116,982 | 222,943 | 339,925 | 48.0% |
| 2026-04-27 | 164,071 | 227,146 | 391,217 | 41.9% |
| 2026-04-20 | 100,601 | 98,969 | 199,570 | 37.3% |
| 2026-04-13 | 82,311 | 191,357 | 273,668 | 49.9% |
| 2026-04-06 | 76,585 | 84,318 | 160,903 | 42.8% |
| 2026-03-30 | 38,394 | 77,517 | 115,911 | 42.7% |
| 2026-03-23 | 95,395 | 145,340 | 240,735 | 41.9% |
| 2026-03-16 | 88,816 | 176,199 | 265,015 | 50.1% |
| 2026-03-09 | 109,423 | 251,780 | 361,203 | 52.4% |
| 2026-03-02 | 107,836 | 289,186 | 397,022 | 48.0% |
| 2026-02-23 | 185,453 | 363,067 | 548,520 | 43.4% |
| 2026-02-16 | 128,626 | 173,952 | 302,578 | 52.9% |
| 2026-02-09 | 96,369 | 156,926 | 253,295 | 42.4% |
| 2026-02-02 | 142,218 | 267,882 | 410,100 | 48.3% |
| 2026-01-26 | 164,393 | 419,658 | 584,051 | 53.1% |
| 2026-01-19 | 184,133 | 307,299 | 491,432 | 45.8% |
| 2026-01-12 | 307,664 | 578,570 | 886,234 | 28.6% |
| 2026-01-05 | 86,074 | 526,824 | 612,898 | 53.5% |
| 2025-12-29 | 104,002 | 199,318 | 303,320 | 56.3% |
| 2025-12-22 | 49,580 | 212,534 | 262,114 | 52.7% |
| 2025-12-15 | 115,254 | 271,262 | 386,516 | 57.3% |
| 2025-12-08 | 101,814 | 485,999 | 587,813 | 41.1% |
| 2025-12-01 | 47,457 | 215,556 | 263,013 | 54.5% |
| 2025-11-24 | 160,485 | 416,309 | 576,794 | 48.8% |
| 2025-11-17 | 297,539 | 1,002,440 | 1,299,979 | 56.9% |
| 2025-11-10 | 64,479 | 258,207 | 322,686 | 41.5% |
| 2025-11-03 | 77,060 | 268,919 | 345,979 | 40.2% |
| 2025-10-27 | 84,250 | 158,041 | 242,291 | 42.2% |
| 2025-10-20 | 55,669 | 272,665 | 328,334 | 54.5% |
| 2025-10-13 | 50,616 | 231,589 | 282,205 | 42.4% |
| 2025-10-06 | 39,995 | 230,780 | 270,775 | 53.2% |
| 2025-09-29 | 45,984 | 421,527 | 467,511 | 50.6% |
| 2025-09-22 | 32,683 | 151,032 | 183,715 | 43.5% |
| 2025-09-15 | 23,259 | 220,028 | 243,287 | 50.1% |
| 2025-09-08 | 139,849 | 289,893 | 429,742 | 63.4% |
| 2025-09-01 | 48,403 | 175,676 | 224,079 | 68.2% |
| 2025-08-25 | 30,063 | 213,157 | 243,220 | 48.3% |
| 2025-08-18 | 7,335 | 185,446 | 192,781 | 56.9% |
| 2025-08-11 | 17,150 | 165,563 | 182,713 | 51.0% |
| 2025-08-04 | 12,886 | 170,776 | 183,662 | 65.4% |
Showing 1–40 of 40 weeks
Key facts
CIK
1176309
CUSIP
68403P203
13F (30d)
11 filings
11 filers
Visit website
Investor relations